الملخص

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a high-risk, but potentially curative, treatment for peritoneal surface malignancies. This retrospective analysis was conducted between March 2023 and September 2025 at Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman, with the objective of analysing perioperative outcomes and challenges in patients undergoing CRS with HIPEC. Data on demographics, intraoperative variables and postoperative outcomes were collected and statistically analysed. A total of 25 consecutive patients were included. The cohort had significant comorbidities (American Society of Anesthesiologists II/III = 84%). Significant metabolic stress was evidenced by increased lactate (P <0.001) and base deficit (P <0.05). Haemodynamic instability necessitated frequent vasopressor use (noradrenaline = 48%). Postoperatively, 20% developed coagulopathy and 16% renal impairment. Thoracic epidural analgesia was primary in 76% of cases. Prolonged ventilation (>5 days) was needed in 12% and the mortality rate was 8% (n = 2); however, this finding should be interpreted with caution given the limited sample size. Meticulous management of haemodynamics, metabolic stress and tailored multimodal analgesia is crucial. Outcomes align with established literature, underscoring the procedure's complexity and the need for optimised protocols to enhance patient safety.

بيانات النشر

المعرّف الرقمي
10.18295/2075-0528.2984
المجلة
مجلة جامعة السلطان قابوس الطبية, 26(1), 276-283
الناشر
جامعة السلطان قابوس
وصول مفتوح
وصول مفتوح ذهبي
الترخيص
CC BY-ND 4.0

اقتبس هذه المقالة

APA 7

Ravi, P. R., AlShaibi, M. A. N., Sahajanandan, R., AlHosni, M. A. S., & Mantha, S. S. (2026). Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A single-institution case series. Sultan Qaboos University Medical Journal, 26(1), 276-283. https://doi.org/10.18295/2075-0528.2984

MLA 9

Ravi, Parli Raghavan, et al. "Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A single-institution case series." Sultan Qaboos University Medical Journal, vol. 26, no. 1, 2026, pp. 276-283. https://doi.org/10.18295/2075-0528.2984.

شيكاغو (المؤلف–التاريخ)

Ravi, Parli Raghavan, Maha Abdullah Naseer AlShaibi, Raj Sahajanandan, Mohammed Abdullah Saif AlHosni, and Srinivas Shyam Mantha. 2026. "Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A single-institution case series." Sultan Qaboos University Medical Journal 26 (1): 276-283. https://doi.org/10.18295/2075-0528.2984.

هارفارد

Ravi, P. R., AlShaibi, M. A. N., Sahajanandan, R., AlHosni, M. A. S. and Mantha, S. S. (2026) 'Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A single-institution case series', Sultan Qaboos University Medical Journal, 26(1), pp. 276-283. doi:10.18295/2075-0528.2984.

فانكوفر

Ravi PR, AlShaibi MAN, Sahajanandan R, AlHosni MAS, Mantha SS. Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A single-institution case series. Sultan Qaboos University Medical Journal. 2026;26(1):276-283. doi:10.18295/2075-0528.2984

IEEE

P. R. Ravi, M. A. N. AlShaibi, R. Sahajanandan, M. A. S. AlHosni, and S. S. Mantha, "Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A single-institution case series," Sultan Qaboos University Medical Journal, vol. 26, no. 1, pp. 276-283, 2026, doi: 10.18295/2075-0528.2984.